An extract of amla fruit (Emblica officinalis), also called Indian gooseberry, was shown to benefit type 2 diabetics with dyslipidemia, according to a new study in Food & Function. Researchers compared a proprietary preparation of amla (Saberry) with the popular diabetes drug metformin in a 90-day, randomized, open-label trial. TheRead
In this study, researchers discovered that a simple extract from the amla plant ((Emblica officinalis, Indian gooseberry), could be a supportive therapy for dyslipidemia, a frequently implicated risk factor for development of atherosclerosis. This study was published in BMC, Complementary and Alternative Medicine. A previously published pilot study, by AntonyRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
